LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 20.68 | 27.76 | 744 | 1119 | 0.6649 | 0.8527 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 20.68 | 27.76 | 1005 | 1119 | 0.8981 | 0.9601 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 20.68 | 27.76 | 1063 | 1119 | 0.9500 | 0.9808 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 22.39 | 27.76 | 18 | 1305 | 0.0138 | -0.0750 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 22.39 | 27.76 | 742 | 1305 | 0.5683 | 0.8066 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 22.39 | 27.76 | 7 | 1305 | 0.0054 | -0.2196 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 22.39 | 27.76 | 819 | 1305 | 0.6272 | 0.8390 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 22.39 | 27.76 | 1081 | 1305 | 0.8279 | 0.9332 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 22.39 | 27.76 | 1125 | 1305 | 0.8616 | 0.9471 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 24.09 | 27.76 | 22 | 1461 | 0.0151 | -0.0398 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 24.09 | 27.76 | 787 | 1461 | 0.5384 | 0.7948 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 24.09 | 27.76 | 9 | 1461 | 0.0062 | -0.1788 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 24.09 | 27.76 | 873 | 1461 | 0.5973 | 0.8276 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 24.09 | 27.76 | 1101 | 1461 | 0.7533 | 0.9033 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 24.09 | 27.76 | 1145 | 1461 | 0.7834 | 0.9164 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 25.79 | 27.76 | 25 | 1605 | 0.0156 | -0.0177 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 25.79 | 27.76 | 805 | 1605 | 0.5015 | 0.7776 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 25.79 | 27.76 | 10 | 1605 | 0.0062 | -0.1601 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 25.79 | 27.76 | 778 | 1605 | 0.4847 | 0.7673 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 25.79 | 27.76 | 1160 | 1605 | 0.7227 | 0.8921 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 25.79 | 27.76 | 1199 | 1605 | 0.7470 | 0.9028 | MN20160318_Q01 | N05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 27.49 | 27.76 | 163 | 1723 | 0.0946 | 0.3461 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 27.49 | 27.76 | 835 | 1723 | 0.4846 | 0.7709 | MN20160318_Q01 | D18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 27.49 | 27.76 | 11 | 1723 | 0.0064 | -0.1439 | MN20160318_Q01 | F14 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 27.49 | 27.76 | 848 | 1723 | 0.4921 | 0.7755 | MN20160318_Q01 | F14 |